Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP

被引:99
|
作者
Hetherington, SL [1 ]
Singh, RK [1 ]
Lodwick, D [1 ]
Thompson, JR [1 ]
Goodall, AH [1 ]
Samani, NJ [1 ]
机构
[1] Univ Leicester, Dept Cardiovasc Sci, Leicester LE1 7RH, Leics, England
关键词
platelets; thrombosis; genes; receptors; adenosine diphosphate;
D O I
10.1161/01.ATV.0000148708.44691.27
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - The platelet ADP receptors P2Y1 and P2Y12 play a pivotal role in platelet aggregation. There is marked interindividual variation in platelet response to ADP. We studied whether genetic variants in the P2Y1 or P2Y12 genes affect platelet response to ADP. Methods and Results - The P2Y1 and P2Y12 genes were screened for polymorphisms. Associations between selected polymorphisms and the platelet response to ADP (0.1, 1.0, and 10 mumol/L), assessed by whole blood flow cytometric measurement of fibrinogen binding to activated glycoprotein IIb-IIIa, were then determined in 200 subjects. Five polymorphisms were found in the P2Y1 gene and 11 in the P2Y12 gene. All polymorphisms were silent. A P2Y1 gene dimorphism, 1622A>G, was associated with a significant (P=0.007) effect on platelet ADP response, with a greater response in carriers of the G allele (frequency 0.15). The effect was seen at all concentrations of ADP but greatest at 0.1 mumol/L ADP, where the response in GG homozygotes was on average 130% higher than that seen in AA homozygotes (P=0.006). Conclusions - A common genetic variant at the P2Y1 locus is associated with platelet reactivity to ADP. This genotype effect partly explains the interindividual variation in platelet response to ADP and may have clinical implications with regard to thrombotic risk.
引用
收藏
页码:252 / 257
页数:6
相关论文
共 50 条
  • [1] Role of P2Y1 purinoceptor in ADP-induced platelet activation
    Savi, P
    Beauverger, P
    Labouret, C
    Delfaud, M
    Salel, V
    Kaghad, M
    Herbert, JM
    FEBS LETTERS, 1998, 422 (03) : 291 - 295
  • [2] The relative importance of the ADP receptors, P2Y12 and P2Y1, in thrombin-induced platelet activation
    Nylander, S
    Mattsson, C
    Ramström, S
    Lindahl, TL
    THROMBOSIS RESEARCH, 2003, 111 (1-2) : 65 - 73
  • [3] Simultaneous Platelet P2Y12 and P2Y1 ADP Receptor Blockade Are Two Better Than One?
    Vaduganathan, Muthiah
    Bhatt, Deepak L.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (03) : 427 - 428
  • [4] Residual platelet ADP reactivity after clopidogrel treatment is dependent on activation of both the unblocked P2Y1 and the P2Y12 receptor and is correlated with protein expression of P2Y12
    Oscar Ö Braun
    Stefan Amisten
    Anna-Karin Wihlborg
    Karen Hunting
    David Nilsson
    David Erlinge
    Purinergic Signalling, 2007, 3 : 195 - 201
  • [5] Residual platelet ADP reactivity after clopidogrel treatment is dependent on activation of both the unblocked P2Y1 and the P2Y12 receptor and is correlated with protein expression of P2Y12
    Braun, Oscar Oe
    Amisten, Stefan
    Wihlborg, Anna-Karin
    Hunting, Karen
    Nilsson, David
    Erlinge, David
    PURINERGIC SIGNALLING, 2007, 3 (03) : 195 - 201
  • [6] Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: Role of P2Y1 and P2Y12 receptors.
    Aslam, Muhammad
    Sedding, Daniel
    Koshty, Ahmed
    Santoso, Santot
    Schulz, Rainer
    Hamm, Christian
    Guenduez, Dursun
    THROMBOSIS RESEARCH, 2013, 132 (05) : 548 - 557
  • [7] Synergistic action between inhibition of P2Y12/P2Y1 and P2Y12/thrombin in ADP- and thrombin-induced human platelet activation
    Nylander, S
    Mattsson, C
    Ramström, S
    Lindahl, TL
    BRITISH JOURNAL OF PHARMACOLOGY, 2004, 142 (08) : 1325 - 1331
  • [8] Extracellular ADP is a powerful osteolytic agent:: evidence for signaling through the P2Y1 receptor on bone cells
    Hoebertz, A
    Meghji, S
    Burnstock, G
    Arnett, TR
    FASEB JOURNAL, 2001, 15 (07) : 1139 - 1148
  • [9] P2Y12, a new platelet ADP receptor, target of clopidogrel
    Savi, P
    Labouret, C
    Delesque, N
    Guette, F
    Lupker, J
    Herbert, JM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 283 (02) : 379 - 383
  • [10] Antiplatelet Therapy Prasugrel: A Novel Platelet ADP P2Y12 Receptor Antagonist
    Mousa, Shaker A.
    Jeske, Walter P.
    Fareed, Jawed
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2010, 16 (02) : 170 - 176